The long-awaited study, which was commissioned by the FDA in hopes of reducing racial bias, found results that contradict past research findings, leaving clinicians confused. Also: FDA Commissioner ...

LSD is a drug often associated with the counter-culture of the 1960s. But it is being studied as a promising therapy for ...

Definium’s late-stage pipeline includes four Phase 3 trials—two each for GAD and MDD—anchored by its lead candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD.

San Francisco’s UCSF is stepping into the national spotlight as one of several university medical centers testing whether a ...

UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...

The results from drugmaker Mindmed tested several doses of LSD in patients with moderate-to-severe generalized anxiety ...

Detailed price information for Betterlife Pharma Inc (BETR-CN) from The Globe and Mail including charting and trades.

Two later-stage trials investigating LSD for treating anxiety are due to conclude in 2026, which could lead to the drug being approved for the common mental health condition ...

In "Source Code: My Beginnings," officially released Feb. 4, 2025, Gates looks back on his formative years with unusual candor, crediting late Microsoft Corp (NASDAQ: MSFT) co-founder Paul Allen as ...

You have /5 articles left. Sign up for a free account or log in. The University of North Carolina at Chapel Hill will close its area studies centers in 2026, faculty ...